Annual Non Current Assets
$295.60 K
-$269.60 K-47.70%
31 December 2023
Summary:
Inhibikase Therapeutics annual long term assets is currently $295.60 thousand, with the most recent change of -$269.60 thousand (-47.70%) on 31 December 2023. During the last 3 years, it has risen by +$295.60 thousand (+100.00%). IKT annual non current assets is now -81.47% below its all-time high of $1.59 million, reached on 31 December 2018.IKT Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$186.80 K
-$37.20 K-16.61%
30 September 2024
Summary:
Inhibikase Therapeutics quarterly long term assets is currently $186.80 thousand, with the most recent change of -$37.20 thousand (-16.61%) on 30 September 2024. Over the past year, it has dropped by -$143.20 thousand (-43.39%). IKT quarterly non current assets is now -86.98% below its all-time high of $1.43 million, reached on 30 September 2020.IKT Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.7% | -43.4% |
| 3 y3 years | +100.0% | +100.0% |
| 5 y5 years | -81.5% | - |
IKT Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -47.7% | -68.6% | ||
| 5 y | 5 years | -81.5% | -87.0% | ||
| alltime | all time | -81.5% | -87.0% |
Inhibikase Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $186.80 K(-16.6%) |
| June 2024 | - | $224.00 K(-13.9%) |
| Mar 2024 | - | $260.30 K(-11.9%) |
| Dec 2023 | $14.21 M(-41.7%) | $295.60 K(-10.4%) |
| Sept 2023 | - | $330.00 K(-9.2%) |
| June 2023 | - | $363.60 K(-32.0%) |
| Mar 2023 | - | $534.80 K(-5.4%) |
| Dec 2022 | $24.37 M | $565.20 K(-5.0%) |
| Sept 2022 | - | $594.80 K(+1280.0%) |
| June 2022 | - | $43.10 K(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | $42.47 M(+187.3%) | $0.00(0.0%) |
| Sept 2021 | - | $0.00(0.0%) |
| June 2021 | - | $0.00(-100.0%) |
| Mar 2021 | - | $2800.00(>+9900.0%) |
| Dec 2020 | $14.78 M(>+9900.0%) | $0.00(-100.0%) |
| Sept 2020 | - | $1.43 M(+326.5%) |
| June 2020 | - | $336.30 K(+3072.6%) |
| Mar 2020 | - | $10.60 K(+265.5%) |
| Dec 2019 | $35.40 K(-97.2%) | $2900.00 |
| Dec 2018 | $1.25 M | - |
FAQ
- What is Inhibikase Therapeutics annual long term assets?
- What is the all time high annual non current assets for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics annual non current assets year-on-year change?
- What is Inhibikase Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics quarterly non current assets year-on-year change?
What is Inhibikase Therapeutics annual long term assets?
The current annual non current assets of IKT is $295.60 K
What is the all time high annual non current assets for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual long term assets is $1.59 M
What is Inhibikase Therapeutics annual non current assets year-on-year change?
Over the past year, IKT annual long term assets has changed by -$269.60 K (-47.70%)
What is Inhibikase Therapeutics quarterly long term assets?
The current quarterly non current assets of IKT is $186.80 K
What is the all time high quarterly non current assets for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly long term assets is $1.43 M
What is Inhibikase Therapeutics quarterly non current assets year-on-year change?
Over the past year, IKT quarterly long term assets has changed by -$143.20 K (-43.39%)